+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Other Building Blocks 14927-64-1
14927-64-1,MFCD09866841
Catalog No.:AA018TTL

14927-64-1 | 3,5,6,7-tetrahydro-s-indacen-1(2H)-one

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
95%
in stock  
$68.00   $48.00
- +
250mg
95%
in stock  
$146.00   $103.00
- +
1g
95%
in stock  
$388.00   $272.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA018TTL
Chemical Name:
3,5,6,7-tetrahydro-s-indacen-1(2H)-one
CAS Number:
14927-64-1
Molecular Formula:
C12H12O
Molecular Weight:
172.2231
MDL Number:
MFCD09866841
SMILES:
O=C1CCc2c1cc1CCCc1c2
Properties

Downstream Synthesis Route

[1]Neudeck,HorstK.[MonatsheftefurChemie,1987,vol.118,p.627-658]

[2]CurrentPatentAssignee:ROCHEHOLDINGAG;SYNCOMB.V.-WO2020/104657,2020,A1Locationinpatent:Page/Pagecolumn129-130

[3]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2019/211463,2019,A1Locationinpatent:Page/Pagecolumn188

[4]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2017/184624,2017,A1Locationinpatent:Page/Pagecolumn207;208

[5]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2019/23147,2019,A1Locationinpatent:Page/Pagecolumn467;468

[6]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2019/23145,2019,A1Locationinpatent:Page/Pagecolumn402;403

[7]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2020/86728,2020,A1Locationinpatent:Page/Pagecolumn305-306

[8]CurrentPatentAssignee:NODTHERALTD-WO2020/249669,2020,A1Locationinpatent:Paragraph0794

[9]Avila,DavidV.;Davies,AlwynG.;Li,ElizabethR.;Ng,KaiM.[JournaloftheChemicalSociety.PerkintransactionsII,1993,#3,p.355-362]

[10]Vejdelek;Holubek;Bartosova;Protiva[CollectionofCzechoslovakChemicalCommunications,1977,vol.42,#10,p.3094-3103]

[11]Agarwal,Sameer;Sasane,Santosh;Shah,HardikA.;Pethani,JigneshP.;Deshmukh,Prashant;Vyas,Vismit;Iyer,Pravin;Bhavsar,Harsh;Viswanathan,Kasinath;Bandyopadhyay,Debdutta;Giri,Poonam;Mahapatra,Jogeswar;Chatterjee,Abhijit;Jain,MukulR.;Sharma,Rajiv[ACSMedicinalChemistryLetters,2020,vol.11,#4,p.414-418]

[12]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2020/102100,2020,A1Locationinpatent:Page/Pagecolumn274-275

[1]Halterman,RonaldL.;Tretyakov,Alexander;Khan,MasoodA.[JournalofOrganometallicChemistry,1998,vol.568,#1-2,p.41-51]

[2]Vejdelek;Bartosova;Protiva[CollectionofCzechoslovakChemicalCommunications,1976,vol.41,#7,p.2020-2033]

[3]CurrentPatentAssignee:IDEMITSUKOSANCOLTD-JP2018/145147,2018,ALocationinpatent:Paragraph0077

[1]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2020/102100,2020,A1Locationinpatent:Page/Pagecolumn274-275

[2]CurrentPatentAssignee:NODTHERALTD-WO2020/249669,2020,A1Locationinpatent:Paragraph0794

[3]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2019/211463,2019,A1Locationinpatent:Page/Pagecolumn188

[4]CurrentPatentAssignee:ROCHEHOLDINGAG;SYNCOMB.V.-WO2020/104657,2020,A1Locationinpatent:Page/Pagecolumn129

[5]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2021/32591,2021,A1Locationinpatent:Page/Pagecolumn191

[6]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2021/150574,2021,A1Locationinpatent:Paragraph0380;0381

[7]Avila,DavidV.;Davies,AlwynG.;Li,ElizabethR.;Ng,KaiM.[JournaloftheChemicalSociety.PerkintransactionsII,1993,#3,p.355-362]

[8]Vejdelek;Bartosova;Protiva[CollectionofCzechoslovakChemicalCommunications,1976,vol.41,#7,p.2020-2033]Woodward,R.B.;Hoye,T.R.[JournaloftheAmericanChemicalSociety,1977,vol.99,p.8007-8014]

[9]Bartmann;Konz;Ruger[JournalofHeterocyclicChemistry,1987,vol.24,#3,p.677-682]

[10]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2017/184624,2017,A1Locationinpatent:Page/Pagecolumn207;208

[11]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2019/23145,2019,A1Locationinpatent:Page/Pagecolumn402;403

[12]Agarwal,Sameer;Sasane,Santosh;Shah,HardikA.;Pethani,JigneshP.;Deshmukh,Prashant;Vyas,Vismit;Iyer,Pravin;Bhavsar,Harsh;Viswanathan,Kasinath;Bandyopadhyay,Debdutta;Giri,Poonam;Mahapatra,Jogeswar;Chatterjee,Abhijit;Jain,MukulR.;Sharma,Rajiv[ACSMedicinalChemistryLetters,2020,vol.11,#4,p.414-418]

[13]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2020/10143,2020,A1Locationinpatent:Page/Pagecolumn346;383

[14]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2020/86728,2020,A1Locationinpatent:Page/Pagecolumn305-306

[15]CurrentPatentAssignee:DISHMANPHARMACEUTICALS&CHEMICALSLIMITED;ROCHEHOLDINGAG-WO2020/79207,2020,A1Locationinpatent:Page/Pagecolumn26-28;32-33

16859-59-9    14927-64-1   
<2-(o-Carboxy-benzyliden)>-s-hydrindacen-1-on 

[1]Neudeck,HorstK.[MonatsheftefurChemie,1989,vol.120,p.597-622]

[1]Bartmann;Konz;Ruger[JournalofHeterocyclicChemistry,1987,vol.24,#3,p.677-682]

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 14927-64-1
13171-00-1

13171-00-1

 162752-17-2

162752-17-2

 16440-98-5

16440-98-5

 16440-97-4

16440-97-4

 24623-20-9

24623-20-9

 24644-78-8

24644-78-8
Building Blocks
More >
Tags:14927-64-1 Molecular Formula|14927-64-1 MDL|14927-64-1 SMILES|14927-64-1 3,5,6,7-tetrahydro-s-indacen-1(2H)-one